MAPT and Dravet syndrome: These findings suggest that NDEs from DS–AD patients can give rise to p-Tau (S396) seeding in the WT mouse brain and lead to Tau pathology spreading from neurons in the hippocampus to oligodendrocytes in the white matter and onto other brain regions, at least after NDE injections into the mouse brain [21].